Standard
FDA Clears Biometric Tool to Assist Clinicians in Diagnosing Autism in Children
Federal regulators have cleared a new technological tool designed to help clinicians identify children with autism, marking another step forward in the integration of artificial intelligence and biometrics into pediatric healthcare. The Food and Drug Administration cleared the tool, known as Neurora, this month to inform clinical decisions regarding the diagnosis of children ranging from…
